Pulmonary Carcinoid Tumor Completed Phase 1 Trials for Trastuzumab (DB00072)

Also known as: Carcinoid tumour pulmonary / Carcinoid tumor of lung / Pulmonary carcinoid tumour

IndicationStatusPhase
DBCOND0028853 (Pulmonary Carcinoid Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment